CD19-targeted CAR T-cell therapy for treatment-refractory autoimmune neuropathies
- DOI
- 10.1016/s1474-4422(25)00199-1
- Published
- 2025-07
- Container
- The Lancet Neurology
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/s1474-4422-25-00199-1,
title = {CD19-targeted CAR T-cell therapy for treatment-refractory autoimmune neuropathies},
author = {Jeremias Motte and Rafael Klimas and Melissa Sgodzai and Charmaine Schücke and Franziska Wunsch and Elena Schmitz and Adriana Rehm and Thomas Mika and Anna Lena Fisse and Dominic Borie and Dimitros Mougiakakos and Aiden Haghikia and Kalliopi Pitarokoili and Roland Schroers and Ralf Gold},
year = {2025},
journal = {The Lancet Neurology},
doi = {10.1016/s1474-4422(25)00199-1},
url = {https://doi.org/10.1016/s1474-4422(25)00199-1}
}RIS
TY - JOUR TI - CD19-targeted CAR T-cell therapy for treatment-refractory autoimmune neuropathies AU - Jeremias Motte AU - Rafael Klimas AU - Melissa Sgodzai AU - Charmaine Schücke AU - Franziska Wunsch AU - Elena Schmitz AU - Adriana Rehm AU - Thomas Mika AU - Anna Lena Fisse AU - Dominic Borie AU - Dimitros Mougiakakos AU - Aiden Haghikia AU - Kalliopi Pitarokoili AU - Roland Schroers AU - Ralf Gold PY - 2025 JO - The Lancet Neurology DO - 10.1016/s1474-4422(25)00199-1 UR - https://doi.org/10.1016/s1474-4422(25)00199-1 ER -
APA
Motte, J., Klimas, R., Sgodzai, M., Schücke, C., Wunsch, F., Schmitz, E., Rehm, A., Mika, T., Fisse, A. L., Borie, D., Mougiakakos, D., Haghikia, A., Pitarokoili, K., Schroers, R., & Gold, R. (2025). CD19-targeted CAR T-cell therapy for treatment-refractory autoimmune neuropathies. The Lancet Neurology. https://doi.org/10.1016/s1474-4422(25)00199-1
Source records
- crossref · retrieved 2026-11-10T14:57:38.368Z